AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Abstract
Mitochondria undergo fragmentation in response to electron transport chain (ETC) poisons and mitochondrial DNA–linked disease mutations, yet how these stimuli mechanistically connect to the mitochondrial fission and fusion machinery is poorly understood. We found that the energy-sensing adenosine monophosphate (AMP)–activated protein kinase (AMPK) is genetically required for cells to undergo rapid mitochondrial fragmentation after treatment with ETC inhibitors. Moreover, direct pharmacological activation of AMPK was sufficient to rapidly promote mitochondrial fragmentation even in the absence of mitochondrial stress. A screen for substrates of AMPK identified mitochondrial fission factor (MFF), a mitochondrial outer-membrane receptor for DRP1, the cytoplasmic guanosine triphosphatase that catalyzes mitochondrial fission. Nonphosphorylatable and phosphomimetic alleles of the AMPK sites in MFF revealed that it is a key effector of AMPK-mediated mitochondrial fission.
Additional Information
© 2016 American Association for the Advancement of Science. Received 28 April 2015; accepted 9 December 2015. This research was supported by NIH grants R01DK080425, R01CA172229, and P01 CA120964 to R.J.S; R01GM062967 and R01GM110039 to D.C.C; R01NS089456 to F.P.; and K99NS091526 to T.L.L. Work in the laboratory of R.J.S. was also supported in part by the Leona M. and Harry B. Helmsley Charitable Trust (grant 2012-PG-MED002). E.Q.T. and N.P.Y. were supported by American Cancer Society fellowships (122123-PF-12-029-01-TBE and 123016-PF-PF-12-191-01-TBE, respectively). S.H. was supported by a European Molecular Biology Organization (EMBO) Long Term Fellowship (ALTF 1101-2013). K.H. was funded by a George E. Hewitt Foundation for Medical Research fellowship. O.C.L. was supported by an American Physiological Society William Townsend Porter predoctoral fellowship. R.J.S. is the William R. Brody Chair at the Salk Institute and a Howard Hughes Medical Institute Early Career Scientist. We thank A. Singh and G. Kasof at Cell Signaling Technology for developing the antibody to MFF P-Ser172 in conjunction with E.Q.T. and R.J.S. We thank the Waitt Biophotonics Core and Flow Cytometry Core at the Salk Institute for use of their instruments, which are supported by the Salk Institute (grant CCSG P30 CA014195). We thank C. Merkwirth and M. Adams for helpful discussions and M. Chun for critical reading of the manuscript.Attached Files
Accepted Version - nihms-778814.pdf
Supplemental Material - aab4138-Toyama-SM-movie-S1.mov
Supplemental Material - aab4138-Toyama-SM-movie-S2.mov
Supplemental Material - aab4138-Toyama-SM-movie-S3.mov
Supplemental Material - aab4138-Toyama-SM-movie-S4.mov
Supplemental Material - aab4138-Toyama-SM-movie-S5.mov
Supplemental Material - aab4138-Toyama-SM.pdf
Files
Name | Size | Download all |
---|---|---|
md5:4ca3f4573703d7bd9cb7d37145a0bc0d
|
1.9 MB | Download |
md5:cf8d4468ed5a671e61bfd94deec3c752
|
2.9 MB | Download |
md5:e4188eb98405884453d790943dc7f365
|
2.3 MB | Download |
md5:c5bbc0e0de7c49a906f92caeaed1f237
|
2.7 MB | Download |
md5:a340e9944d4c5a9cc594fa6c2d348a9c
|
22.2 MB | Preview Download |
md5:9ede0bc05ee64441925fcca102f37c8a
|
931.4 kB | Preview Download |
md5:3ff7a3c58ef58dbf99b5de8807b711ed
|
2.8 MB | Download |
Additional details
- PMCID
- PMC4852862
- Eprint ID
- 64149
- DOI
- 10.1126/science.aab4138
- Resolver ID
- CaltechAUTHORS:20160202-084338645
- NIH
- R01DK080425
- NIH
- R01CA172229
- NIH
- P01 CA120964
- NIH
- R01GM062967
- NIH
- R01GM110039
- NIH
- R01NS089456
- NIH
- K99NS091526
- Leona M. and Harry B. Helmsley Charitable Trust
- 2012-PG-MED002
- American Cancer Society
- 122123-PF-12-029-01-TBE
- American Cancer Society
- 123016-PF-PF-12-191-01-TBE
- European Molecular Biology Organization (EMBO)
- ALTF 1101-2013
- George E. Hewitt Foundation
- American Physiological Society
- Salk Institute
- CCSG P30 CA014195
- Howard Hughes Medical Institute (HHMI)
- Created
-
2016-02-02Created from EPrint's datestamp field
- Updated
-
2022-05-13Created from EPrint's last_modified field